🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07164651
Active, not recruiting Observational

Intelligent Accelerated MRI for Pediatric Abdominal Pain

NCT07164651 · tracked via the Priya Life Science China tracker
Sponsor
Yaqi Shen,MD,PhD
Phase
Observational
Started
2025-05-26
Last updated
2025-09-10

Condition(s) studied

Pediatric Abdominal Pain

Investigational drug(s) / intervention(s)

Accelerated MRI scanning

Accelerated MRI scanning: All patients underwent MRI scans of the abdominal and pelvic regions on the uMR 790 scanner at Tongji Hospital's Optical Valley Campus. The scanning protocol included multiplanar ACS T2WI sequences, TACS T2WI sequences, and conventional T2WI sequences. ACS T2WI sequence: Used for preliminary motion artifact correction. TACS T2WI sequence: Employed for advanced motion artifact correction and provided dynamic images of organ movement. Conventional T2WI sequence: Served as the standard reference for comparison.

Study summary

The goal of this observational study is to evaluate the effectiveness of an intelligent accelerated MRI technique in children with abdominal pain. The main question it aims to answer is:

Does the intelligent accelerated MRI reduce scan time while maintaining diagnostic accuracy in pediatric patients?

Participants will:

Receive an abdominal MRI scan using the accelerated protocol as part of their clinical evaluation.

Have their scan duration and image quality compared to conventional MRI standards.

Eligibility

Sex
ALL
Min age
3 Years
Max age
18 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Children aged 3-18 years presenting with abdominal pain who have undergone abdominal CT examination. * Children whose guardians voluntarily agree to MRI examination and sign written informed consent. Exclusion Criteria: * Children with contraindications to MRI (e.g., metal implants, severe claustrophobia) or those unable to cooperate with the examination.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Tongji Hospital Wuhan Hubei
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07164651 on ClinicalTrials.gov ↗ ← All trials in China